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Abstract 
Purpose: There are still high death rates related to surgeries mainly linked to 
postoperative period. Mortality prediction is one of the greatest challenges posed in 
intensive care and severity of disease scoring systems are the main tool available. The 
aim of this study was to evaluate predictors for postoperative mortality. 
Methods: all adult patients who underwent non-cardiac surgery, admitted in a surgical 
intensive care unit (SICU) for longer than 12 hours between January 2006 and July 
2013 were evaluated. Univariate analysis was carried using Mann-Whitney test, Chi-
Square or Fischer’s exact test. Multivariate analysis with logistic regression was 
performed with calculation of Odds Ratio (OR) with 95% confidence interval (CI). 
Results: 4398 patients met the inclusion criteria. Mortality in SICU was 1.4%. Patients 
dying in the SICU had higher score in severity of disease scoring systems and length of 
stay. Multivariate analyses find 5 independent predictors of mortality in the SICU: 
APACHE II (OR 1.24, CI 1.17-1.30), emergent surgery (OR 4.10, CI 2.12-7.94), 
postoperative serum sodium (OR 1.06, CI 1.01-1.11), serum bicarbonate (OR 0.89, CI 
0.82-0.96), and FiO2 (OR 14.31, CI 3.01-68.07). 
Conclusion: independent predictors of SICU’s mortality were APACHE II, emergent 
surgery, postoperative serum bicarbonate, serum sodium and FiO2. 
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Introduction 
It is estimated that every year 234.2 million people will be submitted to surgery 
worldwide (1). 
According to the 2012 European Surgical Outcomes Study (EuSOS), 4% of patients 
died before hospital discharge (2) and postoperative one-year mortality was 5.5% (3). 
The majority of deaths occur in older patients who undergo major emergent surgery and 
who have severe coexisting diseases as well in those patients that develop complications 
(4-7). 
There are several risk factors described for morbidity and mortality after surgery, which 
may be divided into three categories: patient-related, surgery-related and anesthesia-
related. The risks of surgery and anesthesia are low for the majority of patients and 
evidence increasingly suggests that postoperative complications have a major impact on 
mortality (4, 5, 8). Developed countries have major morbidity due to postoperative 
complications (12 % in United States) (9). Thereof with aging and consequent increase 
of the patient’s co-morbidities, as well as with increasing numbers of patients, there is 
an increase in postoperative morbidity and mortality (5, 10).  
Half of the postoperative adverse events were identified as avoidable (11). Reducing 
rates of postoperative complications and their effective management may be one 
approach in reduce postoperative mortality (4, 5, 9). Immediate postoperative care 
allows a close monitoring and early intervention in order to prevent early postoperative 
complications and deaths. Seriously ill or at increased risk patients’ may require more 
extensive monitoring in a surgical intensive care unit (SICU) which may contribute to a 
better outcome, decreasing morbidity and mortality. However there are few SICU’s 
beds and high costs of their use (12, 13). 
The study of outcome in critical care patients has been primarily focused on hospital 
survival and the resource utilization adjusted according to the severity of illness. 
Intensive care unit (ICU) case fatality rates strongly depend on the severity of illness of 
the individual in the patient population being analyzed (14). 
To improve postoperative care, severity of disease scoring systems were used in order 
to predict the prognosis and estimate the morbidity and mortality of patients. Acting as 
outcome predictors they allow comparisons and the calculation of the expected 
mortality. Acute Physiology and Chronic Health Evaluation II (APACHE II) and 
Simplified Acute Physiology Score II (SAPS II) are two worldwide used severity of 
disease scoring systems (15-17).  
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The severity of scoring systems may be used to predict mortality with the calculation of 
the standardized mortality ratio (SMR), the ratio of observed to predicted mortality, 
which is used as an indicator of the quality of intensive care (18-20), although some 
authors argue that the SMR should not be used to measure the quality of care (21, 22). 
Several risk indices have been developed over the past years based on the relationship 
between comorbidities and perioperative morbidity and mortality. The Revised Cardiac 
Risk Index (RCRI) have become well known and although it isn’t a severity of disease 
score has been used to predict an increased risk of cardiac complications after surgery 
being incorporated in guidelines for the study of preoperative risk factors (23, 24).  
The aim of the present study was to evaluate the determinants of mortality using 
parameters included in severity of disease scoring systems in a cohort of critical surgical 
patients.  
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Methods 
Data collection  
The full study protocol was approved by the research ethics committee of the hospital. 
This prospective cohort study was carried out in the multidisciplinary Post-Anesthesia 
Care Unit (PACU) at the Hospital São João, an 1124-bed community teaching hospital 
in Porto, Portugal. Included in the PACU was a Surgical Intensive Care Unit (SICU) 
with five beds to which critically ill surgical patients are admitted and are closely 
monitored and treated.  
All patients admitted at the SICU who underwent elective or emergent non-cardiac 
surgery between 1
st
 January 2006 and 19
th
 July 2013 were eligible for inclusion. 
Patients less than 18 years old, medical patients, re-admittance for the same medical 
reason during the studied period and SICU length of stay (LOS) lower than 12 hours 
were excluded.  
The following variables were recorded at admission to the SICU: age, type of admission 
(elective or non-elective surgery) and mechanical ventilation.  
For all patients we recorded the SICU LOS and the mortality in the SICU. Major 
cardiac event was defined as at least one of the following: acute myocardial infarction, 
acute pulmonary edema, primary cardiac arrest, ventricular fibrillation/other ventricular 
arrhythmias, complete heart block were assessed (25).  
Organ insufficiency (considering presence of at least one organ failure defined by 
APACHE II) and renal insufficiency (considering creatinine > 2 mg/dL and/or oliguria 
of <500 ml / day) was also evaluated.  
APACHE II and SAPS II were calculated. All variables and parameters included in 
APACHE II and SAPS II scores were evaluated separately (15, 17).  
RCRI was also evaluated using criteria developed by Lee et al: high-risk surgery 
(intraperitoneal, intrathoracic, or suprainguinal vascular procedures), history of 
ischemic heart disease, history of congestive heart disease, preoperative insulin therapy, 
preoperative serum creatinine >2.0 mg/dL and history of cerebrovascular disease (23). 
 
Statistical analysis 
Descriptive analysis of variables was used to summarize data. 
Kolmogorov-Smirnov Test for normality of the underlying population was performed.  
The Mann-Whitney U test, the Chi-square and Fisher’s exact test were used in the 
univariate analyses to compare continuous variables and proportions, respectively.  
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To assess independent predictive factors of postoperative mortality, multivariate 
analysis were performed with multiple binary logistic regression. After applying the 
Bonferroni's correction for multiple comparisons, all the variables included in severity 
of disease scoring systems that had p ≤ 0.001 in the univariate analyses were entered in 
a logistic multiple regression binary analysis with forward elimination method to 
examine covariate effects on mortality calculating an odds ratio (OR) and 95% 
confidence interval (CI)  
The statistical software SPSS version 22.0 for Windows (SPSS, Chicago, IL) was used 
to analyze the data. 
  
8 
 
Results 
During the study period there were 4561 admissions in the SICU and 4398 patients met 
the inclusion criteria. A total of 163 patients were excluded: 53 had a length of SICU 
stay lower than 12 hours, 42 were admitted more than once, 38 were younger than 18 
years old and 30 were admitted for medical reasons. Sixty patients (1.4%) died in the 
SICU. 
Table 1 display the characteristics of all patients enrolled in the study and the 
comparison between patients who survive and patients that have died during SICU stay.  
The median age was 65 years (IQR 54 -74 years) and 61% were male. 
Thirteen percent of patients were admitted after non-elective surgery.  
The median postoperative length of stay for all patients was 20 hours (IQR 16-42 
hours). 
One hundred and seven patients (2.4%) developed major cardiac event that include at 
least one of the following events: acute myocardial infarction (n=59), acute pulmonary 
edema (n=34), primary cardiac arrest (n=19), ventricular fibrillation/other ventricular 
arrhythmias (n=8) and complete heart block (n=4). 
In univariate analyses patients that died were older (median 73 vs 65, p<0.001), were 
more likely to have been submitted to an emergent surgery (60% vs 12%, p<0.001), had 
more frequently mechanical ventilation on admission (83% vs 30%, p<0.001), renal 
insufficiency (35% vs 6%, p<0.001) and organ insufficiency (40% vs 15%, p<0.001). 
Patients that have died in SICU had lower hematocrit (median 29 vs 33, p<0.001), lower 
body temperature (median 34.0 vs 35.8, p<0.001), lower systolic pressure (median 77 vs 
122, p<0.001), lower mean arterial pressure (median 54 vs 85, p<0.001), higher heart 
rate (median 112 vs 83, p<0.001), higher respiratory rate (median 16 vs 14, p<0.001), 
higher urea serum concentration (median 45 vs 30, p<0.001), higher serum creatinine 
(median 15.6 vs 8.2, p<0.001), higher total bilirubin (median 6 vs 4, p<0.001), higher 
FiO2 (median 0.52 vs 0.40, p<0.001), lower PaO2 (median 98 vs 100, p=0.039), higher 
PaCO2 (median 42.7 vs 39.4, p=0.001), lower serum bicarbonate (median 19.4 vs 22.0, 
p<0.001), lower pH (median 7.28 vs 7.40, p<0.001), higher serum sodium (median 145 
vs 140, p<0.001) and had more frequently a glasgow coma scale < 9 (8% vs 1%, 
p<0.001). 
Table 2 displays severity of disease scores, length of stay and major cardiac events. 
Patients that died had higher scores of APACHE II (median 22 vs 8, p<0.001) and 
SAPS II (median 44 vs 18, p<0.001) and had more frequently major cardiac events 
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(28% vs 2%, p<0.001) and had a longer stay (median 46 vs 20, p<0.001) compared to 
survival group. 
As displayed in table 3, patients not surviving had more frequently RCRI scores of more 
than 2 (18% versus 7%, p=0.004). These patients were submitted more frequently to a 
high-risk surgery (80% vs 54%, p<0.001). 
In table 4 are the results of the multivariate analyses that showed that APACHE II (OR 
1.24, 95% CI 1.17-1.30), type of admission as emergent (OR 4.10, 95% CI 2.12-7.94), 
FiO2 (OR 14.31, 95%CI 3.01-68.07) and serum sodium (OR 1.06, 95% CI 1.01-1.11) 
are independent predictors of mortality while serum bicarbonate (for each 1 mmol/L 
increase) was associated with reduced risk of death (OR 0.89, 95% CI 0.82-0.96). 
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Discussion 
In the present study, we assessed the mortality rate of a cohort of surgical critical 
patients after major surgery and studied predictors of mortality analyzing all variables 
included in the severity of score disease APACHE II and SAPS II. 
The principal findings of this study were as follows: that the that mortality rate in the 
SICU was 1.4%; that patients not surviving after SICU admission had higher severity of 
disease scores according to SAPS II and APACHE II, they stayed longer in the SICU 
and had more frequently major cardiac events; almost all variables included in the 
severity of disease scoring systems were different in the group of patients not surviving 
in SICU.  When adjusted for each other and maintaining severity of disease scores in 
the equation only APACHE II, emergent surgery type of admission, inspired fraction of 
oxygen and serum sodium were considered independent factors for mortality while a 
higher serum bicarbonate was associated with a reduction of mortality. 
Early identification of patients at a higher risk of mortality may be important to promote 
treatment and orientation strategies that may preclude case fatalities (4, 6). Severity of 
disease scoring systems may allow us to estimate mortality risk in surgical critical 
patients (15-17) and identifying a group of patients at increased risk of dying. 
Previous studies have been focused on identifying predictors of postoperative mortality 
and morbidity evaluating and quantifying comorbidities, perioperative factors and the 
presence of postoperative complications (3-6, 25-33), but no studies have attempted to 
identify predictors within routine physiological and analytical postoperative parameters 
included in severity of disease scoring systems. 
Type of surgery is a variable that has been studied and clearly found to be related to 
mortality (6, 7, 10, 30, 34) and our results indicate as well that emergent surgery 
patients had a higher mortality rate. It seems that patients undergoing non-elective 
surgeries are likely to have a worse prognosis since they were more severely ill with a 
higher grade of comorbidities with a higher probability of having a less functional 
reserve.  Because of that these patients may be submitted to more complex surgeries and 
they usually require a careful intraoperative care (10, 35). In our study non-elective 
emergent surgery was considered an independent predictor of mortality, increasing the 
probability of dying in the SICU almost 4 times. 
In multivariate analysis FIO2 was another independent predictor of mortality. Higher 
FiO2 is frequently required in patients with impaired tissue oxygenation trying to avoid 
the harmful effects of hypoxia. In fact it is well documented that the PaO2/FiO2 ratio is 
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associated with mortality (36, 37). In our study we did not studied this equation fraction 
but the isolated FiO2 parameter may be considered as a relevant surrogate indicator of 
that fraction. In a previous study higher FiO2 remained an independent predictor of 
mortality even after adjustment for PaO2/FiO2 ratio (38), suggesting poor prognosis not 
only because these patients are more severely ill with impaired tissue oxygenation, but 
also because of hyperoxia and ventilation side-effects (38-40). 
Others have found serum sodium to be a reliable risk factor for mortality (41-45) and it 
is not surprisingly that in this study serum sodium was considered an independent risk 
factor for mortality. Hypernatremia is a common complication in critically ill patients 
such they may be  unconscious, intubated or sedated and may invariably denotes 
hyperosmolar state and transiently intracellular dehydration (46).  
The multivariate analysis of independent variables showed that higher serum 
bicarbonate was associated with a reduction of mortality for each mmol increment 
having a positive impact on survival. This result may indicate that a 
lower serum bicarbonate levels was associated with metabolic acidosis and 
consequently with case fatalities that has been shown by others (47-50). Although the 
deleterious impact of lower serum bicarbonate is well known, both lower and 
higher serum bicarbonates may be associated with increased all-cause mortality as a 
result of the well documented consequences of acid-base abnormalities that have been 
associated with adverse outcomes such as increased mortality (51). However, a recent 
retrospective analysis shows that acidosis itself had no relation with poor outcome 
which was more dependent on severe conditions associated with acidosis (52). 
Age have also been found to have a clear association with postoperative mortality (3, 6, 
53) and that is why is not surprisingly that in our study patients that died in the SICU 
were older. 
In order to stratify the preoperative risk of patients we relied on the RCRI. Patients that 
died had more frequently a score greater or equal than 2 but only high-risk surgery were 
considered a risk factor for mortality and it is interesting that comorbidities included in 
RCRI did not appear to be related to mortality. Perhaps in this particular group of major 
surgery patients the burden of surgery was more relevant than comorbidities. 
Patients with prolonged SICU LOS had higher mortality as LOS is needed in patients 
who develop postoperative complications and those who were more severely ill (7, 25-
27). 
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Data suggest that complication rate varies between 7% and 11% (54). The occurrence of 
postoperative cardiac events is not uncommon, occurring in 2.4% in this study. 
Furthermore mortality group had significantly more major cardiac events, corroborating 
previous studies showing that patients with postoperative major cardiac events had 
higher mortality (25, 26). Indeed previous studies show that cardiovascular 
complications are the leading causes of morbidity in older patients (10) and may be 
associated with 42% of deaths (34). 
We know that many other complications are related to increased risk of mortality (4, 9, 
55) and that many of the surviving patients suffer major complications with a variety of 
morbidity and the consequent reduction of the health and quality of life (26, 56). 
 
Study limitations 
Besides the limitations inherent to a retrospective cohort study, others are present on the 
design of this study. Preoperative risk assessment is roughly based on three broad but 
connected categories including several risk factors: surgery-related, patient-related or 
dependent on patient’s functional status. Not knowing the pre-existing conditions of 
patients beyond the comorbidities present in the Revised Cardiac Risk Index probably 
may also limit the value of conclusions, because comorbidities others than those we 
have studied may be closely related and may have a clear influence on physiological 
parameters included in the severity of disease scoring systems (for example chronic 
obstructive pulmonary disease and PaO2). The lack of an American Society of 
Anesthesiologists physical status (ASA-PS) for our sample population was also 
questionable. Risk prediction models for intraoperative and postoperative mortality 
have included the ASA-PS classification as one strong predictor (24, 57-59).  
Other limitation of the study is the missing data about in-hospital mortality what may be 
viewed as  an important limitation since severity of disease scores and its standard 
mortality rates are related to hospital mortality not to ICU mortality. 
Furthermore, neither intraoperative hemodynamic parameters nor other postoperative 
complications beyond organ insufficiency, renal insufficiency and major cardiac events 
were evaluated in our study and this may be viewed as a limitation that certainly had 
influenced outcome and mortality. 
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Conclusions 
In conclusion postoperative mortality during SICU stay was 1.4%. Fatalities cases had 
significantly higher scores in severity of disease scoring systems as well as had a longer 
SICU stay and more major cardiac events. We have identified independent risk factors 
for mortality: APACHE II, FiO2, serum sodium, type of admission while higher serum 
bicarbonate was associated with a reduction of mortality. 
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Tables 
Table 1: Univariate analysis of mortality predictors in SICU – patients’ characteristics 
Variables 
Total 
N=4398 
Survival group 
N=4338 
Mortality group 
N=60 
p value 
Gender, n (%)    
0.518 
a)
 Male 2681 (61.0) 2642 (60.9) 39 (65.0) 
Female 1717 (39.0) 1696 (39.1) 21 (35.0) 
Age, median (IQR) 65.0 (54.0-74.0) 65.0 (53.0-74.0) 72.5 (59.5-79.8) <0.001
 b)
 
Type of admission, n (%)    
<0.001
 a)
 Elective surgery 3827 (87.0) 3803 (87.7) 24 (40.0) 
Non-elective surgery 571 (13.0) 535 (12.3) 36 (60.0) 
Mechanical ventilation on 
admission, n (%) 
1341 (30.5) 1291 (29.8) 50 (83.3) <0.001
 a)
 
Renal insufficiency, n (%) 285 (6.5) 264 (6.1) 21 (35.0) <0.001
f)
 
Organ insufficiency, n (%) 682 (15.5) 658 (15.2) 24 (40.0) <0.001
 a)
 
Hematocrit, median (IQR) 33.0 (29.8-36.3) 33.0 (29.9-36.4) 28.8 (22.9-33.0) <0.001
 b)
 
Body temperature, median (IQR)  35.4 (34.6-36.0) 35.8 (34.6-36.0) 34.0 (33.0-35.3) <0.001
 b)
 
Systolic pressure, median (IQR) 122.0 (102.0-144.0) 122.0 (102.0-144.0) 76.5 (66.0-88.8) <0.001
 b)
 
Mean arterial pressure, median 
(IQR) 
85.0 (71.0-96.0) 85.0 (71.0-96.0) 53.0 (47.3-63.0) <0.001
 b)
 
Heart rate, median (IQR) 83 (69-98) 83 (68-98) 112 (88-133) <0.001
 b)
 
Respiratory rate, median (IQR) 14 (12-16) 14 (12-16) 16 (14-16) <0.001
 b)
 
Serum urea, median (IQR) 30.0 (20.0-40.0) 30.0 (20.0-40.0) 45.0 (23.5-70.0) 0.001
 b)
 
Serum creatinine, median (IQR) 8.3 (6.5-11.0) 8.2 (6.5-11.0) 15.6 (9.0-25.3) <0.001
 b)
 
Total bilirrubin, median (IQR) 4.0 (1.0-7.0) 4.0 (1.0-7.0) 6.0 (4.0-10.8) <0.001
 b)
 
FiO2, median (IQR) 0.40 (0.35-0.40) 0.40 (0.34-0.40) 0.52 (0.40-1.00) <0.001
 b)
 
PaO2, median (IQR) 100.0 (100.0-110.0) 100.0 (100.0-110.0) 98.0 (75.5-138.6) 0.039
 b)
 
PaCO2, median (IQR) 39.5 (35.0-45.0) 39.4 (35.0-45.0) 42.7 (36.0-54.0) 0.001
 b)
 
Serum bicarbonate, median (IQR) 22.0 (21.0-24.0) 22.0 (21.0-24.0) 19.4 (17.0-22.0) <0.001
 b)
 
pH, median (IQR) 7.40 (7.35-7.40) 7.40 (7.35-7.40) 7.28 (7.17-7.35) <0.001
 b)
 
Serum potassium, median (IQR) 3.80 (3.40-4.10) 3.80 (3.40-4.10) 3.90 (3.13-4.45) 0.806
 b)
 
Serum sodium, median (IQR) 140 (137-142) 140 (137-142) 145 (140-152) <0.001
 b)
 
Leucocytes count, median (IQR) 11.0 (8.0-14.0) 11.0 (8.0-11.0) 9.5 (4.0-19.0) 0.230
 b)
 
21 
 
Glasgow coma scale (<9), n (%) 54 (1.2) 46 (1.1) 8 (13.3) <0.001
f)
 
APACHE II: Acute Physiology and Chronic Health Evaluation; IQR: Interquartile range (P25-P75); 
SAPS II: Simplified Acute Physiology Score; SICU: Surgical Intensive Care Unit 
a)
Chi-Square test 
b)
 Mann-Whitney test 
f)
 p value with Fisher's Exact Test 
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Table 2: Univariate analysis of mortality predictors in SICU - severity of disease scores, 
length of stay and major cardiac event. 
 
Variables 
Total 
N=4398 
Survival group 
N=4338 
Mortality 
group 
N=60 
p value 
APACHE II, median (IQR) 8.0 (6.0-12.0) 8.0 (6.0-12.0) 22.0 (19.0-26.0) <0.001
 b)
 
SAPS II, median (IQR) 18.0 (13.3-26.7) 18.0 (13.3-25.0) 43.7 (37.8-57.8) <0.001
 b)
 
SICU LOS(hours), median (IQR) 20.0 (16.0-42.0) 20.0 (16.0-41.0) 46.0 (19.5-82.8) <0.001
b)
 
Major cardiac event , n (%) 107 (2.4) 90 (2.1) 17 (28.3) <0.001
f)
 
APACHE II: Acute Physiology and Chronic Health Evaluation; IQR: Interquartile range (P25-P75); LOS: 
length of stay; SAPS II: Simplified Acute Physiology Score; SICU: Surgical Intensive Care Unit  
b)
 Mann-Whitney test 
f)
 p value with Fisher's Exact Test 
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Table 3: Univariate analysis of mortality predictors in SICU - Criteria developed by Lee 
et al 
Variables 
Total 
N=4398 
Survival 
group 
N=4338 
Mortality group 
N=60 
p value 
High-risk surgery, n (%) 2382 (54.2) 2334 (53.8) 48 (80.0) <0.001
 a)
 
History of ischemic heart disease, n (%) 617 (14.0) 607 (14.0) 10 (16.7) 0.554
 a)
 
History of congestive heart disease, n (%) 691 (15.7) 673 (15.5) 18 (30.0) 0.002
 a)
 
Preoperative insulin therapy, n (%) 215 (4.9) 213 (4.9) 2 (3.3) 1
f)
 
Preoperative serum creatinine >2.0 
mg/dL, n (%) 
281 (6.4) 272 (6.3) 9 (15.0) 0.013
f)
 
History of cerebrovascular disease, n (%) 559 (12.7) 548 (12.6) 11 (18.3) 0.188
 a)
 
RCRI ≥2, n (%) 328 (7.5) 317 (7.3) 11 (18.3) 0.004f) 
RCRI: Revised Cardiac Risk Index; SICU: Surgical Intensive Care Unit 
a)
Chi-Square test 
f)
 p value with Fisher's Exact Test 
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Table 4: Multiple logistic regression analysis for independent predictors of mortality in 
SICU 
Variables OR 
a) 
(95% IC) p 
b)
 value 
APACHE II  1.25 (1.18- 1.31) <0.001 
Type of admission 3.88 (2.02- 7.46) <0.001 
FIO2 21.25 (4.75- 95.16) <0.001 
Serum bicarbonate 0.88 (0.82- 0.95) 0.001 
Serum sodium 1.06 (1.01- 1.11) 0.01 
APACHE II: Acute Physiology and Chronic Health Evaluation; CI: confidence interval; OR: odds ratio; 
SICU: Surgical Intensive Care Unit;  
 
a)
 Adjusted for age, mechanical ventilation on admission, renal insufficiency, organ insufficiency, 
hematocrit, body temperature, systolic pressure, mean arterial pressure, heart rate, respiratory rate, serum 
urea, serum creatinine, total bilirubin, FiO2, PaCO2, serum bicarbonate, pH, serum sodium, glasgow 
coma scale and SAPS II 
b)
 A logistic regression analysis with inclusion severity of disease scoring systems’ variables with p≤0.001 
was used. 
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research, the principal results and major conclusions. An abstract is often presented separately from
the article, so it must be able to stand alone. For this reason, References should be avoided, but if
essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should
be avoided, but if essential they must be defined at their first mention in the abstract itself.
Abstract
Note: Research papers should contain a structured abstract of no more than 200 words which contain
the following:
1.Purpose: Why was this study done?
2.Materials and Methods: What was the source of the data generated? How was it obtained?
3.Results: Findings should be objectively reported and statistical significance indicated (if
appropriate).
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4.Conclusions: Do not include a summary at the end of the paper.
Graphical abstract
Although a graphical abstract is optional, its use is encouraged as it draws more attention to the online
article. The graphical abstract should summarize the contents of the article in a concise, pictorial form
designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a
separate file in the online submission system. Image size: Please provide an image with a minimum
of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 ×
13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office
files. See http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best
presentation of their images and in accordance with all technical requirements: Illustration Service.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and
avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing
with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords
will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page
of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first
mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those
individuals who provided help during the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Embedded math equations
If you are submitting an article prepared with Microsoft Word containing
embedded math equations then please read this related support information
(http://support.elsevier.com/app/answers/detail/a_id/302/).
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or
use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the printed version.
• Submit each illustration as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then
please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is
finalized, please 'Save as' or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of
500 dpi.
Please do not:
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• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a
low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or
MS Office files) and with the correct resolution. If, together with your accepted article, you submit
usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in
color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations
are reproduced in color in the printed version. For color reproduction in print, you will receive
information regarding the costs from Elsevier after receipt of your accepted article. Please
indicate your preference for color: in print or on the Web only. For further information on the
preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications that can arise by converting color figures to 'gray
scale' (for the printed version should you not opt for color in print) please submit in addition usable
black and white versions of all the color illustrations.
Illustration services
Elsevier's WebShop (http://webshop.elsevier.com/illustrationservices) offers Illustration Services
to authors preparing to submit a manuscript but concerned about the quality of the images
accompanying their article. Elsevier's expert illustrators can produce scientific, technical and medical-
style images, as well as a full range of charts, tables and graphs. Image 'polishing' is also available,
where our illustrators take your image(s) and improve them to a professional standard. Please visit
the website to find out more.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables
below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be
sparing in the use of tables and ensure that the data presented in tables do not duplicate results
described elsewhere in the article.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal
communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the
journal and should include a substitution of the publication date with either 'Unpublished results' or
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted
for publication.
Reference links
Increased discoverability of research and high quality peer review are ensured by online links to
the sources cited. In order to allow us to create links to abstracting and indexing services, such as
Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please
note that incorrect surnames, journal/book titles, publication year and pagination may prevent link
creation. When copying references, please be careful as they may already contain errors. Use of the
DOI is encouraged.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any
further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a
different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in
the text) to other articles in the same Special Issue.
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Reference style
Text: Indicate references by number(s) in square brackets in line with the text. The actual authors
can be referred to, but the reference number(s) must always be given.
List: Number the references (numbers in square brackets) in the list in the order in which they appear
in the text.
Examples:
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun
2010;163:51–9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith
RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281–304.
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first
6 should be listed followed by 'et al.' For further details you are referred to 'Uniform Requirements
for Manuscripts submitted to Biomedical Journals' (J Am Med Assoc 1997;277:927–34) (see also
http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Journal abbreviations source
Journal names should be abbreviated according to the List of Title Word Abbreviations:
http://www.issn.org/services/online-services/access-to-the-ltwa/.
Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific
research. Authors who have video or animation files that they wish to submit with their article are
strongly encouraged to include links to these within the body of the article. This can be done in the
same way as a figure or table by referring to the video or animation content and noting in the body
text where it should be placed. All submitted files should be properly labeled so that they directly
relate to the video file's content. In order to ensure that your video or animation material is directly
usable, please provide the files in one of our recommended file formats with a preferred maximum
size of 50 MB. Video and animation files supplied will be published online in the electronic version
of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com.
Please supply 'stills' with your files: you can choose any frame from the video or animation or
make a separate image. These will be used instead of standard icons and will personalize the
link to your video data. For more detailed instructions please visit our video instruction pages at
http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded
in the print version of the journal, please provide text for both the electronic and the print version
for the portions of the article that refer to this content.
AudioSlides
The journal encourages authors to create an AudioSlides presentation with their published article.
AudioSlides are brief, webinar-style presentations that are shown next to the online article on
ScienceDirect. This gives authors the opportunity to summarize their research in their own words and
to help readers understand what the paper is about. More information and examples are available at
http://www.elsevier.com/audioslides. Authors of this journal will automatically receive an invitation
e-mail to create an AudioSlides presentation after acceptance of their paper.
Supplementary data
Elsevier accepts electronic supplementary material to support and enhance your scientific research.
Supplementary files offer the author additional possibilities to publish supporting applications, high-
resolution images, background datasets, sound clips and more. Supplementary files supplied will be
published online alongside the electronic version of your article in Elsevier Web products, including
ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is
directly usable, please provide the data in one of our recommended file formats. Authors should
submit the material in electronic format together with the article and supply a concise and descriptive
caption for each file. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
The following list will be useful during the final checking of an article prior to sending it to the journal
for review. Please consult this Guide for Authors for further details of any item.
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Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
• Phone numbers
All necessary files have been uploaded, and contain:
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge)
and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black-and-white versions of the figures are also supplied for
printing purposes
For any further information please visit our customer support site at http://support.elsevier.com.
AFTER ACCEPTANCE
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI
consists of a unique alpha-numeric character string which is assigned to a document by the publisher
upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal
medium for citing a document, particularly 'Articles in press' because they have not yet received their
full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the
journal Physics Letters B):
http://dx.doi.org/10.1016/j.physletb.2010.09.059
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to
change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in
the e-mail so that authors can download the files themselves. Elsevier now provides authors with
PDF proofs which can be annotated; for this you will need to download Adobe Reader version 9 (or
higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files
will accompany the proofs (also given online). The exact system requirements are given at the Adobe
site: http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including
replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections
quoting line number. If, for any reason, this is not possible, then mark the corrections and any other
comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan
the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing,
completeness and correctness of the text, tables and figures. Significant changes to the article as
accepted for publication will only be considered at this stage with permission from the Editor. We
will do everything possible to get your article published quickly and accurately. It is important to
ensure that all corrections are sent back to us in one communication: please check carefully before
replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely
your responsibility.
Other Funding Body Policies
Elsevier has also worked with the following funding bodies to ensure that our authors can comply
with their policies:
- Arthritis Research Campaign (UK)
- British Heart Foundation (UK)
- Cancer Research (UK)
- Chief Scientist Office
- Department of Health (UK)
- Howard Hughes Medical Institute (US)
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- Medical Research Council (UK)
- Wellcome Trust (UK)
For full details on how these policies are implemented, please see complete information at:
http://www.elsevier.com/wps/find/authorsview.authors/fundingbodyagreements.
AUTHOR INQUIRIES
You can track your submitted article at http://help.elsevier.com/app/answers/detail/a_id/89/p/8045/.
You can track your accepted article at http://www.elsevier.com/trackarticle. You are also welcome to
contact Customer Support via http://support.elsevier.com.
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